Isis Pharmaceuticals is engaged in discovering and developing novel drugs for its product pipeline and for its partners through the exploitation of its leadership position in antisense technology. The company’s pipeline consists of 28 drugs to treat a broad range of diseases, with emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer. Isis’ drugs and technology are covered by the strong and extensive protection of its patents. For more information, visit the company’s Web site: http://www.isispharm.com
Let us hear your thoughts below: